Persist AI Teams up with Microsize and Micromacinazione (Micmac) to Launch First-of-Its-Kind Early-Stage "Micromill" Formulation Platform, Enabling Drug Development Decision With Milligrams of API
New collaboration delivers a fully integrated formulation workflow from early solubility studies to high-throughput dissolution, stability, and in-process analytics, making drug formulation less artisanal and more deterministic at milligram scale
SAN FRANCISCO, June 3, 2026 /PRNewswire/ -- Persist AI, an AI and robotics-powered pharmaceutical formulation research company, today